Andrew Turitz, EVP, CORPORATE DEVELOPMENT at Teladoc Health, Inc. (TDOC), sold 41,546 shares at $7.26 ($302K) on 2024-09-04, disclosed to the SEC on 2024-09-05.
Scheduled sale ($302k) by EVP, CORPORATE DEVELOPMENT under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.26 | 20,773 | $151K | 50.0% |
| 2 | $7.26 | 20,773 | $151K | 50.0% |
| Total | $7.26 avg | 41,546 | $302K | 100% |
| Filing → |
| TDOC | SELL | 2024-03-06 | $164K | — | Filing → |
| TDOC | SELL | 2024-03-05 | $187K | — | Filing → |
| TDOC | SELL | 2023-12-05 | $8K | — | Filing → |